These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27511478)

  • 1. High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis.
    He T; Liu X; Li Y; Liu XY; Wu QY; Liu ML; Yuan H
    J Hum Hypertens; 2017 Feb; 31(2):79-88. PubMed ID: 27511478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
    Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy.
    Ma J; Wang XY; Hu ZD; Zhou ZR; Schoenhagen P; Wang H
    J Thorac Dis; 2015 Dec; 7(12):2243-52. PubMed ID: 26793346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.
    Lv Y; Zou Z; Chen GM; Jia HX; Zhong J; Fang WW
    Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　- The NOCTURNE Study.
    Kario K; Tomitani N; Kanegae H; Ishii H; Uchiyama K; Yamagiwa K; Shiraiwa T; Katsuya T; Yoshida T; Kanda K; Hasegawa S; Hoshide S
    Circ J; 2017 Jun; 81(7):948-957. PubMed ID: 28321001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy].
    Kuriyama S; Tomonari H; Ohtsuka Y; Ohkido I; Hosoya T
    Nihon Jinzo Gakkai Shi; 2003; 45(4):367-71. PubMed ID: 12806973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R; Weir MR
    J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effectiveness of ARB plus CCB therapy and high-dose ARB therapy in high-risk elderly hypertensive patients: subanalysis of the OSCAR study.
    Kim-Mitsuyama S; Ogawa H; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K;
    Hypertens Res; 2015 Mar; 38(3):199-207. PubMed ID: 25471234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: a meta-analysis.
    Alviar CL; Devarapally S; Nadkarni GN; Romero J; Benjo AM; Javed F; Doherty B; Kang H; Bangalore S; Messerli FH
    Am J Hypertens; 2013 Feb; 26(2):287-97. PubMed ID: 23382415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
    Konoshita T; Kaeriyama S; Urabe M; Nakaya T; Yamada M; Ichikawa M; Yamamoto K; Sato S; Imagawa M; Fujii M; Makino Y; Zenimaru Y; Wakahara S; Suzuki J; Ishizuka T; Nakamura H;
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA; Tsourous GI; Marakomichelakis GE; Katsanou PM; Fotia ME; Vassilopoulos CV; Diamantopoulos EJ
    J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
    Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.
    Koyanagi R; Hagiwara N; Yamaguchi J; Kawada-Watanabe E; Haruta S; Takagi A; Ogawa H;
    J Cardiol; 2013 Oct; 62(4):217-23. PubMed ID: 23778009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.